title: Ensuring safety of DNA vaccines.
abstract: In 1990 a new approach for vaccination was invented involving injection of plasmid DNA in vivo, which elicits an immune response to the encoded protein. DNA vaccination can overcome most disadvantages of conventional vaccine strategies and has potential for vaccines of the future. However, today 15 years on, a commercial product still has not reached the market. One possible explanation could be the technique's failure to induce an efficient immune response in humans, but safety may also be a fundamental issue. This review focuses on the safety of the genetic elements of DNA vaccines and on the safety of the microbial host for the production of plasmid DNA. We also propose candidates for the vaccine's genetic elements and for its microbial production host that can heighten the vaccine's safety and facilitate its entry to the market.
authors.affiliation: Bioneer A/S, DK-2970 Hørsholm, Denmark. jag@bioneer.dk
authors.forename: Jacob
authors.initials: J
authors.lastname: Glenting
authors.forename: Stephen
authors.initials: S
authors.lastname: Wessels